DK158836C - Analogifremgangsmaade til fremstilling af terapeutisk aktive anthraquinonderivater - Google Patents

Analogifremgangsmaade til fremstilling af terapeutisk aktive anthraquinonderivater

Info

Publication number
DK158836C
DK158836C DK358678A DK358678A DK158836C DK 158836 C DK158836 C DK 158836C DK 358678 A DK358678 A DK 358678A DK 358678 A DK358678 A DK 358678A DK 158836 C DK158836 C DK 158836C
Authority
DK
Denmark
Prior art keywords
anthraquino
analogue
derivatives
preparation
therapeutic active
Prior art date
Application number
DK358678A
Other languages
Danish (da)
English (en)
Other versions
DK358678A (da
DK158836B (da
Inventor
Keith Chadwick Murdock
Frederick Emil Durr
Ralph Grassing Child
Original Assignee
American Cyanamid Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=27542240&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK158836(C) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from US05/903,292 external-priority patent/US4138415A/en
Application filed by American Cyanamid Co filed Critical American Cyanamid Co
Publication of DK358678A publication Critical patent/DK358678A/da
Publication of DK158836B publication Critical patent/DK158836B/da
Application granted granted Critical
Publication of DK158836C publication Critical patent/DK158836C/da

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N31/00—Investigating or analysing non-biological materials by the use of the chemical methods specified in the subgroup; Apparatus specially adapted for such methods
    • G01N31/22—Investigating or analysing non-biological materials by the use of the chemical methods specified in the subgroup; Apparatus specially adapted for such methods using chemical indicators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J45/00—Ion-exchange in which a complex or a chelate is formed; Use of material as complex or chelate forming ion-exchangers; Treatment of material for improving the complex or chelate forming ion-exchange properties
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G59/00—Polycondensates containing more than one epoxy group per molecule; Macromolecules obtained by polymerising compounds containing more than one epoxy group per molecule using curing agents or catalysts which react with the epoxy groups
    • C08G59/18—Macromolecules obtained by polymerising compounds containing more than one epoxy group per molecule using curing agents or catalysts which react with the epoxy groups ; e.g. general methods of curing
    • C08G59/40—Macromolecules obtained by polymerising compounds containing more than one epoxy group per molecule using curing agents or catalysts which react with the epoxy groups ; e.g. general methods of curing characterised by the curing agents used
    • C08G59/62—Alcohols or phenols
    • C08G59/621—Phenols
    • C08G59/623—Aminophenols
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G59/00—Polycondensates containing more than one epoxy group per molecule; Macromolecules obtained by polymerising compounds containing more than one epoxy group per molecule using curing agents or catalysts which react with the epoxy groups
    • C08G59/18—Macromolecules obtained by polymerising compounds containing more than one epoxy group per molecule using curing agents or catalysts which react with the epoxy groups ; e.g. general methods of curing
    • C08G59/68—Macromolecules obtained by polymerising compounds containing more than one epoxy group per molecule using curing agents or catalysts which react with the epoxy groups ; e.g. general methods of curing characterised by the catalysts used
    • C08G59/686—Macromolecules obtained by polymerising compounds containing more than one epoxy group per molecule using curing agents or catalysts which react with the epoxy groups ; e.g. general methods of curing characterised by the catalysts used containing nitrogen
    • C—CHEMISTRY; METALLURGY
    • C10—PETROLEUM, GAS OR COKE INDUSTRIES; TECHNICAL GASES CONTAINING CARBON MONOXIDE; FUELS; LUBRICANTS; PEAT
    • C10M—LUBRICATING COMPOSITIONS; USE OF CHEMICAL SUBSTANCES EITHER ALONE OR AS LUBRICATING INGREDIENTS IN A LUBRICATING COMPOSITION
    • C10M1/00—Liquid compositions essentially based on mineral lubricating oils or fatty oils; Their use as lubricants
    • C10M1/08—Liquid compositions essentially based on mineral lubricating oils or fatty oils; Their use as lubricants with additives
    • C—CHEMISTRY; METALLURGY
    • C10—PETROLEUM, GAS OR COKE INDUSTRIES; TECHNICAL GASES CONTAINING CARBON MONOXIDE; FUELS; LUBRICANTS; PEAT
    • C10M—LUBRICATING COMPOSITIONS; USE OF CHEMICAL SUBSTANCES EITHER ALONE OR AS LUBRICATING INGREDIENTS IN A LUBRICATING COMPOSITION
    • C10M133/00—Lubricating compositions characterised by the additive being an organic non-macromolecular compound containing nitrogen
    • C10M133/02—Lubricating compositions characterised by the additive being an organic non-macromolecular compound containing nitrogen having a carbon chain of less than 30 atoms
    • C10M133/04—Amines, e.g. polyalkylene polyamines; Quaternary amines
    • C10M133/12—Amines, e.g. polyalkylene polyamines; Quaternary amines having amino groups bound to a carbon atom of a six-membered aromatic ring

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Polymers & Plastics (AREA)
  • Biochemistry (AREA)
  • Analytical Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Biophysics (AREA)
  • General Physics & Mathematics (AREA)
  • Physics & Mathematics (AREA)
  • Hematology (AREA)
  • Oncology (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Pathology (AREA)
  • Epidemiology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
DK358678A 1977-08-15 1978-08-14 Analogifremgangsmaade til fremstilling af terapeutisk aktive anthraquinonderivater DK158836C (da)

Applications Claiming Priority (10)

Application Number Priority Date Filing Date Title
US82487277A 1977-08-15 1977-08-15
US82487277 1977-08-15
US87317478A 1978-01-30 1978-01-30
US87304078A 1978-01-30 1978-01-30
US87304178A 1978-01-30 1978-01-30
US87304078 1978-01-30
US87317478 1978-01-30
US87304178 1978-01-30
US05/903,292 US4138415A (en) 1978-05-05 1978-05-05 1,4-Bis(aminoalkylamino)-anthraquinones and leuco derivatives thereof
US90329278 1978-05-05

Publications (3)

Publication Number Publication Date
DK358678A DK358678A (da) 1979-02-16
DK158836B DK158836B (da) 1990-07-23
DK158836C true DK158836C (da) 1991-01-14

Family

ID=27542240

Family Applications (1)

Application Number Title Priority Date Filing Date
DK358678A DK158836C (da) 1977-08-15 1978-08-14 Analogifremgangsmaade til fremstilling af terapeutisk aktive anthraquinonderivater

Country Status (22)

Country Link
JP (1) JPS6463556A (it)
AR (1) AR225884A1 (it)
AT (1) AT359484B (it)
AU (1) AU527103B2 (it)
BE (1) BE869688A (it)
CH (1) CH644840A5 (it)
DD (1) DD139256A5 (it)
DE (1) DE2835661A1 (it)
DK (1) DK158836C (it)
FI (1) FI70882C (it)
FR (1) FR2400504A1 (it)
GB (1) GB2004293B (it)
GR (1) GR74415B (it)
IE (1) IE47253B1 (it)
IL (1) IL55218A (it)
IT (1) IT1107773B (it)
NL (1) NL188981C (it)
NO (2) NO148777C (it)
NZ (1) NZ187989A (it)
PL (1) PL122586B1 (it)
PT (1) PT68420A (it)
SE (1) SE445996B (it)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4275009A (en) * 1979-05-29 1981-06-23 American Cyanamid Company 1-(Aminoalkylamino)-5,8-dihydroxy-4-substituted-anthraquinones
US4275010A (en) * 1979-10-24 1981-06-23 American Cyanamid Company 5,8-Dihydroxy-1,4-bis(guanidinylamino)anthraquinones
US4296030A (en) * 1980-04-09 1981-10-20 American Cyanamid Company Metal chelates of 1,4-bis(substituted-amino-5,8-dihydroxy-anthraquinones
US4278605A (en) * 1980-06-30 1981-07-14 American Cyanamid Company Heteroalkylenebisanthraquinones
EP0052853A1 (de) * 1980-11-24 1982-06-02 Hoechst Aktiengesellschaft Bis-Aminomethyl-anthrachinon-Derivate, Verfahren zu ihrer Herstellung, sie enthaltende Mittel und ihre Verwendung
EP0083683A1 (en) * 1981-10-26 1983-07-20 American Cyanamid Company Method of preparing 1,4-bis(substituted-amino)-5,8-dihydroxyanthraquinones and pharmaceutical compositions containing them
EP0154117B1 (en) * 1984-02-27 1989-12-27 American Cyanamid Company Use of 1,4 bis(substituted) anthrachinones for the manufacture of immunosuppresiva
EP0182135A3 (en) * 1984-11-19 1987-08-05 American Cyanamid Company Novel bis-(substituted amino) anthraquinones
US5436243A (en) * 1993-11-17 1995-07-25 Research Triangle Institute Duke University Aminoanthraquinone derivatives to combat multidrug resistance
GB9815910D0 (en) * 1998-07-21 1998-09-23 Btg Int Ltd Synthetic method
DE602004019687D1 (de) * 2003-12-23 2009-04-09 Somanta Ltd Anthraquinonderivate als mittel gegen krebs
US8173621B2 (en) 2008-06-11 2012-05-08 Gilead Pharmasset Llc Nucleoside cyclicphosphates
CL2009002206A1 (es) 2008-12-23 2011-08-26 Gilead Pharmasset Llc Compuestos derivados de pirrolo -(2-3-d]-pirimidin-7(6h)-tetrahidrofuran-2-il fosfonamidato, composicion farmaceutica; y su uso en el tratamiento de enfermedades virales.
EP2376514A2 (en) 2008-12-23 2011-10-19 Pharmasset, Inc. Nucleoside analogs
NZ593648A (en) 2008-12-23 2013-09-27 Gilead Pharmasset Llc Nucleoside phosphoramidates
KR101715981B1 (ko) 2010-03-31 2017-03-13 길리애드 파마셋 엘엘씨 뉴클레오사이드 포스포르아미데이트
DE102012203981A1 (de) * 2012-03-14 2013-09-19 Henkel Ag & Co. Kgaa Mittel zum Färben und/oder Mattieren von keratinhaltigen Fasern enthaltend neuartige1,4-Diaminoanthrachinonfarbstoffe
GB201214169D0 (en) 2012-08-08 2012-09-19 Biostatus Ltd New compounds and uses thereof

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR1422016A (fr) * 1962-10-29 1965-12-24 Oreal Nouveaux colorants anthraquinoniques et leur application à la teinture des cheveux
GB1157506A (en) * 1965-09-10 1969-07-09 Ilford Ltd Anthraquinone Dye Colour Couplers and their use in Colour Photographic Materials
US3646072A (en) * 1970-07-27 1972-02-29 Du Pont Turquoise biscationic anthraquinone dyes
US3700398A (en) * 1970-07-27 1972-10-24 Du Pont Process for dyeing acid-modified nylon fibers
US4051155A (en) * 1975-12-15 1977-09-27 Allied Chemical Corporation Anthraquinone dyes

Also Published As

Publication number Publication date
IE47253B1 (en) 1984-02-08
CH644840A5 (de) 1984-08-31
FI70882C (fi) 1986-10-27
SE445996B (sv) 1986-08-04
NL188981C (nl) 1992-12-01
AU3877678A (en) 1980-02-14
AT359484B (de) 1980-11-10
GB2004293B (en) 1982-06-23
NO150482B (no) 1984-07-16
IL55218A (en) 1983-03-31
FR2400504B1 (it) 1981-06-26
ATA590678A (de) 1980-04-15
IT7850730A0 (it) 1978-08-14
GR74415B (it) 1984-06-28
DE2835661A1 (de) 1979-03-01
NZ187989A (en) 1981-07-13
DD139256A5 (de) 1979-12-19
NO148777C (no) 1984-01-25
PL209065A1 (it) 1980-01-02
BE869688A (fr) 1979-02-12
AU527103B2 (en) 1983-02-17
NO150482C (no) 1984-10-24
DK358678A (da) 1979-02-16
FI782481A (fi) 1979-02-16
IT1107773B (it) 1985-11-25
DK158836B (da) 1990-07-23
FI70882B (fi) 1986-07-18
JPS6463556A (en) 1989-03-09
NO820290L (no) 1979-02-16
PL122586B1 (en) 1982-08-31
DE2835661C2 (it) 1991-08-22
GB2004293A (en) 1979-03-28
NO782756L (no) 1979-02-16
PT68420A (en) 1978-09-01
NO148777B (no) 1983-09-05
NL7808475A (nl) 1979-02-19
IE781636L (en) 1979-02-15
FR2400504A1 (fr) 1979-03-16
AR225884A1 (es) 1982-05-14
SE7807987L (sv) 1979-02-16
JPH0217534B2 (it) 1990-04-20

Similar Documents

Publication Publication Date Title
NO148148C (no) Fremgangsmaate til fremstilling av terapeutisk aktive 4-hydroksy-2-pyrrolidinonderivater
DK148751C (da) Fremgangsmaade til fremstilling af cyclosporinderivater
NO149035C (no) Analogifremgangsmaate for fremstilling av fysiologisk aktive acylanilid-derivater
DK536178A (da) Fremgangsmaade til fremstilling af stilbenderivater
DK129578A (da) Fremgangsmaade til fremstilling af oximderivater af 3-acetoxymethyl-7-aminothiazolylacetamidocephalosporansyre
DK481678A (da) Fremgangsmaade til fremstilling af imidazolidinderivater
NO147421C (no) Analogifremgangsmaate for fremstilling av farmakologisk aktive 4-acylamino-fenyl-etanolaminer
DK158836C (da) Analogifremgangsmaade til fremstilling af terapeutisk aktive anthraquinonderivater
DK162225C (da) Fremgangsmaade til fremstilling af lactoner af cyclopropancarboxylsyrer
DK170678A (da) Fremgangsmaade til fremstilling af n-alkyl-n-acyl-derivater af thienamycin
DK30578A (da) Fremgangsmaade til fremstilling af aminoalkoxyphenylderivater
DK129678A (da) Fremgangsmaade til fremstilling af oximderivater af 7-aminothiazolylacetamidocephalosporansyre
NO151288C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive indolokinolizindiner
DK50778A (da) Fremgangsmaade til fremstilling af oxadiazolopyrimidinderivater
NO145843C (no) Analogifremgangsmaate til fremstilling av terapeutisk virksomme n1-glukofuranosid-6-yl-n3-nitroso-urinstoffer
DK50878A (da) Fremgangsmaade til fremstilling af oxadiazolopyrimidinderivater
NO780644L (no) Fremgangsmaate til fremstilling av terapeutisk virksomme 9-hydroksyetoksymetylguanin-derivater
DK295378A (da) Fremgangsmaade til fremstilling af terapeutisk virksomme diarylalkylaminer
DK68978A (da) Fremgangsmaade til fremstilling af oximderivater af 3-thiadiazolythiomethyl-7-aminothiazolylacetamidocephalosporansyre
DK529278A (da) Fremgangsmaade til fremstilling af farmaceutisk virksomme thiolestere
DK246878A (da) Fremgangsmaade til fremstilling af acylderivater
DK61778A (da) Fremgangsmaade til fremstilling af everninominderivater
DK553378A (da) Fremgangsmaade til fremstilling af 1-hydrocarbylpyrrol-2-eddikesyrederivater
DK525978A (da) Fremgangsmaade til fremstilling af clavulansyrederivater
NO142839C (no) Analogifremgangmsmaate for fremstilling av terapeutisk aktive triazolo-tieno-diazepinderivater

Legal Events

Date Code Title Description
PUP Patent expired